Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema

International Archives of Allergy and Immunology

Volumn 166, Issue 4, 2015, Pages 259-266

  Petraroli, Angelica ^a   Squeglia, Veronica ^a   Di Paola, Nadia ^b   Barbarino, Alessandro ^a   Bova, Maria ^a   Spanò, Rosanna ^b   Marone, Gianni ^a   Triggiani, Massimo ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Departments of Economics Management Institutions   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Cost minimization; Hereditary angioedema; Home therapy; Plasma derived C1 inhibitor; Self administration

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; ICATIBANT;

ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COST MINIMIZATION ANALYSIS; FEMALE; HEALTH CARE COST; HOME CARE; HOSPITALIZATION; HUMAN; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCHOOL CHILD; TIME TO TREATMENT; TRAINING; ANGIOEDEMAS, HEREDITARY; DRUG SELF ADMINISTRATION; ECONOMICS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATIENT EDUCATION; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANGIOEDEMAS, HEREDITARY; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; SELF ADMINISTRATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84928654653     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000381341     Document Type: Article

References (42)

1. Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, Caballero T, Farkas H, Grumach A, Kaplan AP, Riedl MA, Triggiani M, Zanichelli A, Zuraw B: Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 2014; 69: 602-616.
2. Longhurst H, Cicardi M: Hereditary angiooedema. Lancet 2012; 379: 474-481.
3. Bygum A: Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol 2009; 161: 1153-1158.
4. Ghazi A, Grant JA: Hereditary angioedema: epidemiology, management, and role of icatibant. Biologics 2013; 7: 103-113.
5. Roche O, Blanch A, Caballero T, Sastre N, Callejo D, Lopez-Trascasa M: Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol 2005; 94: 498-503.
6. Zanichelli A, Arcoleo F, Barca MP, Borrelli P, Bova M, Cancian M, Cicardi M, Cillari E, De Carolis C, De Pasquale T, Del Corso I, Cesinaro Di Rocco P, Guarino MD, Massaro I, Minale P, Montinaro V, Neri S, Perricone S, Pucci S, Quattrocchi P, Rossi O, Triggiani M, Zanierato G, Zoli A: A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy. Orphanet J Rare Dis 2015;10:11.
7. Aygoren-Pursun E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Wait S, Boysen HB, Caballero T: Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet J Rare Dis 2014; 9: 99.
8. Nordenfelt P, Dawson S, Wahlgren CF, Lindfors A, Malbris L, Bjorkander J: Quantifying the burden of disease health state in patients with hereditary angioedema in Sweden. Allergy Asthma Proc 2014; 35: 185-90.
9. Wilson DA, Bork K, Shea EP, Rentz AM, Blaustein MB, Pullman WE: Economic costs associated with acute attacks and long-term management of hereditary angioedema. Ann Allergy Asthma Immunol 2010; 104: 314-320.
10. Tilles SA, Borish L, Cohen JP: Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives. Ann Allergy Asthma Immunol 2013; 110: 70-74.
11. Cicardi M, Bellis P, Bertazzoni G, Cancian M, Chiesa M, Cremonesi P, Marino P, Montano N, Morselli C, Ottaviani F, Perricone R, Triggiani M, Zanichelli A: Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts. Intern Emerg Med 2014; 9: 85-92.
12. Zilberberg MD, Nathanson BH, Jacobsen T, Tillotson G: Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 2004-2007. Allergy Asthma Proc 2011; 32: 248-254.
13. Cicardi M, Craig TJ, Martinez-Saguer I, Hebert J, Longhurst HJ: Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on self-administration. Int Arch Allergy Immunol 2013; 161(suppl 1):3-9.
14. Bork K, Steffensen I, Machnig T: Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review. Allergy Asthma Proc 2013; 34: 312-327.
15. Boysen HB, Bouillet L, Aygoren-Pursun E: Challenges of C1-inhibitor concentrate selfadministration. Int Arch Allergy Immunol 2013; 161(suppl 1):21-25.
16. Caballero T, Sala-Cunill A, Cancian M, Craig TJ, Neri S, Keith PK, Boccon-Gibod I, Bethune C, Bork K: Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema. Int Arch Allergy Immunol 2013; 161(suppl 1): 10-16.
17. Longhurst HJ, Farkas H, Craig T, Aygoren-Pursun E, Bethune C, Bjorkander J, Bork K, Bouillet L, Boysen H, Bygum A, Caballero T, Cicardi M, Dempster J, Gompels M, Gooi J, Grigoriadou S, Huffer U, Kreuz W, Levi MM, Long J, Martinez-Saguer I, Raguet M, Reshef A, Bowen T, Zuraw B: HAE international home therapy consensus document. Allergy Asthma Clin Immunol 2010; 6: 22.
18. Bygum A, Andersen KE, Mikkelsen CS: Selfadministration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur J Dermatol 2009; 19: 147-151.
19. Kreuz W, Rusicke E, Martinez-Saguer I, Aygoren-Pursun E, Heller C, Klingebiel T: Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema. Transfusion 2012; 52: 100-107.
20. Levi M, Choi G, Picavet C, Hack CE: Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 2006; 117: 904-908.
21. Bork K, Meng G, Staubach P, Hardt J: Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 2005; 45: 1774-1784.
22. Rizk C, Karsh J, Santucci S, Yang W: Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema. CMAJ 2013; 185: 791-792.
23. Craig TJ. Recent advances in hereditary angioedema self-administration treatment: summary of an international hereditary angioedema expert meeting. Int Arch Allergy Immunol 2013; 161(suppl 1):26-27.
24. Symons C, Rossi O, Magerl M, Andritschke K: Practical approach to self-administration of intravenous C1-INH concentrate: a nursing perspective. Int Arch Allergy Immunol 2013; 161(suppl 1):17-20.
25. SPC icatibant. 2013. http://www.ema.Europa. Eu/docs/en-gb/document-library/epar-product-information/human/000899/wc500022966.Pdf (accessed June 12, 2014).
26. SPC Berinert. 2013. https://www.Medicines. Org.Uk/emc/medicine/21650/spc/berinert+500+iu/(accessed June 12, 2014).
27. Decreto ministeriale del 18/10/2012. http://www.Crob.It/crob/files/docs/10/63/33/document-file-106333.Pdf (accessed June 12, 2014).
28. Decreto del commissario ad acta No 32 del 27/03/13. http://www.Arsan.Campania.It/documents/10157/2fa38e7f-28c4-470eb7c0-3fef24b080ac (accessed June 12, 2014).
29. Determinazione No 57 del 17 giugno 2013. http://www.Soresa.It (accessed June 12, 2014).
30. ACI. 2014. http://servizi.Aci.It/ckinternet/selezionemodello (accessed June 12, 2014).
31. ISTAT: Struttura delle retribuzioni 2010. 2013. http://www.Istat.It/it/archivio/83362 (accessed June 12, 2014).
32. Allen DW: An alternative method for assessing the value of housewife services. 2004. http://www.economica.ca/ew09-1p2.htm (accessed June 12, 2014).
33. OECD: Education at a glance 2012: OECD indicators. 2012.http://www.oecd.org/edu/EAG%202012-e-book-EN-200912.pdf (last accessed June 12, 2014).
34. Bygum A: Hereditary angioedema-consequences of a new treatment paradigm in Denmark. Acta Derm Venereol 2014; 94: 436-441.
35. Gregory C, Landmesser LM, Corrigan L, Mariano D: Feasibility of home infusion and self-administration of nanofiltered C1 esterase inhibitor for routine prophylaxis in patients with hereditary angioedema and characterization of a training and support program. J Infus Nurs 2014; 37: 29-34.
36. Rusicke E, Martinez-Saguer I, Aygoren-Pursun E, Kreuz F: Home treatment in patients with hereditary angioedema (HAE) (abstract). J Allergy Clin Immunol 2006; 117:S180.
37. Tuong LA, Olivieri K, Craig TJ. Barriers to selfadministered therapy for hereditary angioedema. Allergy Asthma Proc 2014; 35: 250-254.
38. Tourangeau LM, Castaldo AJ, Davis DK, Koziol J, Christiansen SC, Zuraw BL: Safety and efficacy of physician-supervised selfmanaged C1 inhibitor replacement therapy. Int Arch Allergy Immunol 2012; 157: 417-424.
39. Bork K, Staubach P, Hardt J. Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angioedema. Allergy 2008; 63: 751-757.
40. Maurer M, Aberer W, Bouillet M, Caballero T, Fabien V, Kanny G, Kaplan A, Longhurst H, Zanichelli A; IOS Investigators: Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS One 2013; 8:e53773.
41. Abdel-Karim O, Dizdarevic A, Bygum A: Hereditary angioedema: children should be considered for training in self-administration. Pediatr Dermatol 2014; 31:e132-135.
42. Blasco AJ, Lazaro P, Caballero T, Guilarte M: Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain. Health Econ Rev 2013; 3: 2.